You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Cell Therapy: Facility Design

Mar 17, 2017

Insights

Cell Therapy: Facility Design

Mar 17, 2017

In 1931, Dr. Paul Niehans injected a preparation of live cells from a parathyroid gland into a dying patient. The patient subsequently recovered and Dr. Niehans had an eureka moment that injections of living cells can have tremendous therapeutic value.

 

Today, there are 13 FDA-approved cellular therapies and over 10,000 clinical trials open for cell therapies. In comparison, there are approximately 3,000 trials open for antibodies. This small number of currently approved cellular therapy products verses the large number of trials raises the odds that a large gap in manufacturing capacity is imminent.

To read more go to http://www.pharmpro.com/blog/2017/03/cell-therapy-facility-design

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue